CCAT2-mediated drug resistance was further documented to be supported by ERK/MAPK signaling, and the silencing of either ERK/MAPK and CCAT2 resulted in increased apoptosis and necrosis in tamoxifen-resistant BC [211]. The gene discussed is CCAT2; the disease is breast cancer.